• Non ci sono risultati.

BIBLIOGRAFIA IMMAGINI

N/A
N/A
Protected

Academic year: 2021

Condividi "BIBLIOGRAFIA IMMAGINI"

Copied!
4
0
0

Testo completo

(1)

BIBLIOGRAFIA IMMAGINI

Numero figura 1. http://www.eophtha.com/eophtha/anatomy/anatomyofuvea3.html 2. http://www.johnyfit.com/acute-glaucoma/ 3. https://lh6.googleusercontent.com/gq_p9EjBEOs/TW0yePJcgmI/AAAAAA AAAEE/t3PewLZQvQk/s400/TRABECOLE1.gif

4. ThePathophysiologyandTreatmentofGlaucoma Areview RobertN. Weinreb ,MD; TinAung,MD, PhD; FelipeA. Medeiros, MD, PhD

5. Shiose Y et al., Jpn J Ophthalmol. 1991 Prevalenza di POAG, NTG e OHT in Giappone

6. The Pathophysiology and Treatmentof Glaucoma Areview RobertN. Weinreb ,MD; TinAung,MD, PhD; FelipeA. Medeiros, MD, PhD

7. ThePathophysiologyandTreatmentofGlaucoma Areview RobertN. Weinreb ,MD; TinAung,MD, PhD; FelipeA. Medeiros, MD, PhD

8. http://www.sandomeniconline.it/oculistica/ attivita-ambulatoriale/ tonografia. Html

9. https://it.wikipedia.org/wiki/Gonioscopia

10.http://preventglaucoma.blogspot.it/2013/01/glaucoma-anatomy- blog.html

11.Steele, R. M.; Batugo, M. R.; Benedini, F.; Biondi, S.; Borghi, V.; Carzaniga, L.; Impagnietello, F.; Miglietta, D.; Chong, W. K. M.; Rajapakse, R.; Cecchi, A.; Temperini, C.; Supuran C. T., Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. Bioorg. Med. Chem. Lett. 2009, 19, 6565-6570.

(2)

12.Prostaglandin analogues in the anterior eye: Their pressure lowering action and side effects Kathryn PB Cracknell*, Ian Grierson St. Paul’s Unit of Ophthalmology, Department of Medicine, Royal Liverpool

University Hospital, Liverpool L69 3GA, UK

13.https://www.microchirurgiaoculare.com/malattie-dell- occhio/glaucoma/intervento-glaucoma-mini-invasivo

14.The Pathophysiology and Treatmentof Glaucoma Areview RobertN. Weinreb ,MD; TinAung,MD, PhD; FelipeA. Medeiros, MD, PhD

15.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K. Donegan and Raquel L. Lieberman School of Chemistry and

Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United States

16.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K. Donegan and Raquel L. Lieberman School of Chemistry and

Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United States

17.https://en.wikipedia.org/wiki/Angiopoietin

18.https://it.wikipedia.org/wiki/Delta-9-tetraidrocannabinolo 19.https://en.wikipedia.org/wiki/Cochlin

20.Rosenthal, R.; Fromm, M. Endothelin antagonism as an active principle for glaucoma therapy. Br. J. Pharmacol. 2011, 162, 806−816.

21.https://it.wikipedia.org/wiki/Endotelina_1

(3)

22.http://www.keyum.net/it/pag/blog-keyum-5/news/curiosita-11/2015/03/grelina-205

23.https://es.wikipedia.org/wiki/Latrunculina 24.https://en.wikipedia.org/wiki/MMP2

25. http://www.anagen.net/mela.htm

26.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K. Donegan and Raquel L. Lieberman School of Chemistry and

Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United States

27.Fuchshofer, R.; Tamm, E. R. The role of TGF-β in the pathogenesis of primary open-angle glaucoma. Cell Tissue Res. 2012.

BIBLIOGRAFIA TABELLE

Numero tabella

1. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K.

Donegan and Raquel L. Lieberman School of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United State

2. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K.

Donegan and Raquel L. Lieberman School of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United State

(4)

3. Prostaglandin analogues in the anterior eye: Their pressure lowering action and side effects Kathryn PB Cracknell*, Ian Grierson St. Paul’s Unit of Ophthalmology, Department of Medicine, Royal Liverpool University Hospital, Liverpool L69 3GA, UK

4. Prostaglandin analogues in the anterior eye: Their pressure lowering action and side effects Kathryn PB Cracknell*, Ian Grierson St. Paul’s Unit of Ophthalmology, Department of Medicine, Royal Liverpool University Hospital, Liverpool L69 3GA, UK

5. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K.

Donegan and Raquel L. Lieberman School of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United State

6. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K.

Donegan and Raquel L. Lieberman School of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United State

7. Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions Miniperspective Rebecca K.

Donegan and Raquel L. Lieberman School of Chemistry and Biochemistry, Georgia Institute of Technology, 901 Atlantic Drive NW, Atlanta, Georgia 30332-0400, United State

Riferimenti

Documenti correlati

GITR, glucocorticoid-induced TNF receptor-related gene; TNF, tumor necrosis factor; GITR-L, glucocorticoid-induced TNF receptor-related gene ligand; LAG-3, lymphocyte

Hence, the aim of this study was to assess the pharmacokinetics of LSP after intravenous (IV), intramuscular (IM) and oral (PO) administration in sheep at a dosage of 50 mg..

In Section 3 we recall the general algorithm for reducing a matrix into Hessenberg form by means of Givens rotations and prove the main result, expressed in Theorem 3.2, on

Ogni paper può essere citato come parte degli "Atti della XXII Conferenza Nazionale SIU, L'urbanistica italiana di fronte all'Agenda 2030.. Portare territori e comunità sulla

Figure 5: Potential wave power advantage on different offshore geometries - Each coloured square shows two numbers: the first (without brackets) is the incident wave power on the

Top 20 entrepreneurs for “Celebrity” Ranking Name Place of birth Date of birth Place of death Date of death Education level Main sector of activity Ways of company acquisition Short